Factors highly predictive of ScGVHD in a multivariable regression model
| Variable . | Nonsclerotic . | Sclerotic . | P in model . |
|---|---|---|---|
| TBI in reduced-intensity setting | 1 (6.67%) | 14 (93.33%) | .0114 |
| C3, mg/dL | 120.93 (2.62) | 144.21 (2.97) | < .001 |
| Platelets, 1000/μL | 224.86 (10.06) | 293.47 (11.37) | .0011 |
| Variable . | Nonsclerotic . | Sclerotic . | P in model . |
|---|---|---|---|
| TBI in reduced-intensity setting | 1 (6.67%) | 14 (93.33%) | .0114 |
| C3, mg/dL | 120.93 (2.62) | 144.21 (2.97) | < .001 |
| Platelets, 1000/μL | 224.86 (10.06) | 293.47 (11.37) | .0011 |
For each of the groups, fibrotic and nonfibrotic, continuous variables are shown as means and standard errors. Categorical variables are shown as proportions with percentages for each group.
ScGVHD indicates sclerotic-type chronic GVHD; and TBI, total body irradiation.